Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

Aortic Regurgitation clinical trials

4 of 7 indexed Aortic Regurgitation trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Aortic Regurgitation: 7 US clinical trials tracked, 4 recruiting.

Aortic Regurgitation is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is JenaValve Technology, running 4 of these trials.

Enrollment posture brief

Registry condition aortic-regurgitation

OPEN 4 | RECR 57% | LATE 0 | EARLY 0 | RANK #2497 | SPON 4

Volume-matched condition peers

Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)

ACL Tear71.4%ACL57.1%Aortic Regurgitation (this)57%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Aortic Regurgitation

Aortic Regurgitation lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Aortic Regurgitation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Aortic Regurgitation is recruiting above its size-band peers.

    4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Aortic Regurgitation research.

    JenaValve Technology accounts for 4 of 7 trials (57.1%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Typical Aortic Regurgitation enrolment sits around 180 participants.

    Median target enrolment is 180 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.

  4. Aortic Regurgitation research is mostly interventional.

    5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

JenaValve Technology 4 trials
The Cleveland Clinic 2 trials
JC Medical, Inc., an affiliate of Edwards Lifesciences 1 trials

Named interventions

Most-linked intervention names on Aortic Regurgitation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

JenaValve Trilogy Heart Valve System Device
2 trials
JenaValve Pericardial TAVR System Device
1 trials
J-Valve TF System Device
1 trials
Transcatheter Aortic Valve Replacement (TAVR) using Trilogy THV System Device
1 trials
Quality of Life Questionnaire Other
1 trials
CMR Diagnostic test
1 trials
MRI with strain measurement Diagnostic test
1 trials
SAVR Device
1 trials

US sites by state

Facility locations filed on Aortic Regurgitation trials. A trial with sites in several states counts in each.

Ohio 5 trials
New York 5 trials
Texas 4 trials
Michigan 4 trials
Georgia 4 trials
District of Columbia 4 trials
California 4 trials
Minnesota 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Aortic Regurgitation page

7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Aortic Regurgitation condition card totals 7 registered trials; most-linked intervention JenaValve Trilogy Heart Valve System; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.